Figure 5

Area overlap (AO) and spectral correlation coefficient (SCC) percentages of freeze-dried bevacizumab, bevacizumab-loaded NP and thermally denatured bevacizumab. Results are significantly different (**p < 0.01, ****p < 0.0001) from native bevacizumab.